Prosecution Insights
Last updated: October 02, 2026
Application No. 18/483,151

SYNERGISTIC DUAL CURE FOR RAPID MANUFACTURING OF THERMOSET MATERIAL

Non-Final OA §102§112
Filed
Oct 09, 2023
Priority
Oct 07, 2022 — provisional 63/414,238 +1 more
Examiner
WHITELEY, JESSICA
Art Unit
1763
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Alliance for Energy Innovation, LLC
OA Round
1 (Non-Final)
89%
Grant Probability
Favorable
1-2
OA Rounds
0m
Est. Remaining
96%
With Interview

Examiner Intelligence

Grants 89% — above average
89%
Career Allowance Rate
1359 granted / 1533 resolved
+23.6% vs TC avg
Moderate +7% lift
Without
With
+7.0%
Interview Lift
resolved cases with interview
Fast prosecutor
1y 11m
Avg Prosecution
31 currently pending
Career history
1560
Total Applications
across all art units

Statute-Specific Performance

§101
1.5%
-38.5% vs TC avg
§103
33.4%
-6.6% vs TC avg
§102
34.0%
-6.0% vs TC avg
§112
18.4%
-21.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1533 resolved cases

Office Action

§102 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Claim18-20 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected invention, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on July 8, 2026. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 4 and 12 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. With regards to claim 4, the claim states the term “AIBN” but does not specify the meaning of said term rendering the claim indefinite. With regards to claim 12, the claim states the term “PECAN” but does not specify the meaning of said term rendering the claim indefinite. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claims 1-17 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Rolland et al (WO 2017/112653). With regards to claim 1, Rolland teaches a method of forming a dual cure three-dimensional object (abstract) by mixing a first precursor liquid and a second precursor liquid to product a polymerizable liquid (abstract). Rolland then teaches the composition to be cured wherein the curing is carried out concurrently due to the irradiation step generating heat from polymerization of the first component in an amount sufficient to thermally solidify or polymerize the second component (page 4). With regards to claims 2, 9, and 12, Rolland teaches the compounds to be covalently bonded to one another (pages 6-7) forming an interpenetrating polymer network (page 4). With regards to claims 3 and 4, Rolland teaches the component that polymerizes from heat to include organic peroxides (page 41). With regards to claims 5-8, Rolland teaches the addition of isobornyl acrylate (page 135). With regards to claim 10, Rolland teaches the other component to include an epoxy (page 144). With regards to claim 11, Rolland teaches the composition to include an imidazole compound (pages 47-48). With regards to claim 13, Rolland teaches the ratio of the second compound to the first compound to be 1:22 (page 135) and for the temperature of the polymerization to be from 50 to 100°C (page 4). With regards to claim 14, Rolland teaches one reactant to be an epoxy and one reactant to be a (meth)acrylate (page 144) and the process to include mixing the two components and solidifying or curing said composition to form an interpenetrating polymer network (page 4). With regards to claim 15, Rolland teaches the composition to include a photoinitiator (abstract) and for the polymerizing steps to first include irradiating the composition with light (page 4). With regards to claim 16, Rolland teaches the photoinitiator to include acetophenone such as diethoxyacetophenone (page 55). With regards to claim 17, Rolland teaches the composition to polymerize/cure under ultraviolet (UV) light (pages 18-19). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to JESSICA WHITELEY whose telephone number is (571)272-5203. The examiner can normally be reached 8 - 5:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Joseph Del Sole can be reached at 5712721130. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JESSICA WHITELEY/Primary Examiner, Art Unit 1763
Read full office action

Prosecution Timeline

Oct 09, 2023
Application Filed
Aug 25, 2026
Non-Final Rejection mailed — §102, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12748349
PHOTOSENSITIVE RESIN COMPOSITION AND DISPLAY DEVICE INCLUDING THE SAME
3y 10m to grant Granted Sep 29, 2026
Patent 12747363
ACTIVE ENERGY RAY-CURABLE INKJET INK COMPOSITION
3y 4m to grant Granted Sep 29, 2026
Patent 12741414
PARTICULATE BUILD MATERIALS FOR THREE-DIMENSIONAL PRINTING
3y 6m to grant Granted Sep 22, 2026
Patent 12735380
SYNTHESIS OF PARA-ALKYLATED SYRINGYL (METH)ACRYLATE DERIVATIVES AND PHOTOPOLYMERIZABLE COMPOSITIONS FOR ADDITIVE MANUFACTURING IN DENTAL APPLICATIONS
3y 8m to grant Granted Sep 15, 2026
Patent 12735381
CARDANOL-BASED REACTIVE DILUENTS AND THEIR USE AND PREPARATION
3y 0m to grant Granted Sep 15, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
89%
Grant Probability
96%
With Interview (+7.0%)
1y 11m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1533 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month